Reducing workplace dust limits could significantly reduce silicosis cases Scientists have found that a worker's lifetime exposure to "permissible" levels of silica dust results in a considerable risk of developing silicosis. Aug 7, 2024 0 26
In probing brain-behavior nexus, big datasets are better When designing machine learning models, researchers first train the models to recognize data patterns and then test their effectiveness. But if the datasets used to train and test aren't sufficiently large, models may appear ... Aug 7, 2024 0 36
Flesh-eating bacteria kills Texas man infected after fishing along Gulf Coast A 66-year-old Texas man died of an infection caused by a flesh-eating bacteria he contracted while fishing along the Gulf Coast. Aug 7, 2024 0 90
Tongue-tie in babies explained Up to 10% of newborns are born with ankyloglossia, a condition more commonly known as tongue-tie. The most common symptom for infants is difficulty with breastfeeding or bottlefeeding. The American Academy of Pediatrics is ... Aug 7, 2024 0 33
Exploring the link between time perspective and life satisfaction in adulthood Humans can relate to the passage of time differently, experiencing a multitude of thoughts and emotions about their past, present and future. In psychology, these time-related mental representations are collectively referred ... Aug 7, 2024 feature 0 206
Skin-to-skin 'kangaroo care' found to boost neurodevelopment in preemies Skin-to-skin cuddling with a parent has lasting cognitive benefits for premature babies, according to a new Stanford Medicine study. Preemies who received more skin-to-skin contact, also known as kangaroo care, while hospitalized ... Aug 7, 2024 0 119
A mixed-methods investigation of patient food and dietary preferences The socioeconomic and cultural factors that influence what people eat can cause inequities that are detrimental to health, especially in underserved communities. The Food is Medicine movement strives to reduce these disparities ... Aug 7, 2024 0 43
FDA approves new therapy for glioma patients for first time in decades Vorasidenib has been approved by the U.S. Food and Drug Administration (FDA) for patients with Grade 2 gliomas with IDH1 or IDH2 mutations. Aug 7, 2024 0 50
Cancer stem cell-immune cell crosstalk in the tumor microenvironment for liver cancer progression The complex dynamics between liver cancer stem cells (CSCs) and immune cells within the tumor microenvironment (TME) are central to the progression of liver cancer. These interactions are critical in creating an immunosuppressive ... Aug 7, 2024 0 64
The battle against glioblastoma: Classifying molecular profiles for precision medicine Glioblastoma multiforme (GBM) stands as a formidable adversary in oncology, characterized by its molecular complexity and relentless progression. Despite advancements, the high degree of tumor heterogeneity and its tendency ... Aug 7, 2024 0 38
